CVS Health (CVS) Tops Q3 EPS by 1c; Narrows EPS Outlook, Raising Midpoint
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
CVS Health Reports Third Quarter Results
November 6, 2017 6:55 AM ESTWOONSOCKET, R.I., Nov. 6, 2017 /PRNewswire/ --
Third Quarter Year-over-year Highlights:
Net revenues increased 3.5% to $46.2 billion GAAP diluted EPS from continuing operations of $1.26 Adjusted EPS of $1.50Year-to-date Highlights:
Generated cash flow from operations of $8.1 billion; free cash flow of $7.0 billion2017 Guidance:
Narrowed and raised the mid-point of the range for full year GAAP diluted EPS from continuing operations to $4.98 to $5.02 from $4.92 to $5.02 Narrowed and raised the mid-point of the range for full year... More